TETRAPHASE PHARMACEUTICALS INC Accretion Expense
TETRAPHASE PHARMACEUTICALS INC reported Accretion Expense of $45.00 thousand for the 12-month period ending 2015-12-31, per its 10-K filed 2018-03-06.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AccretionExpense · last filed 2018-03-06
- TETRAPHASE PHARMACEUTICALS INC accretion expense for the quarter ending 2015-12-31 was $0.00, a 100.00% decline year-over-year.
- TETRAPHASE PHARMACEUTICALS INC accretion expense for the quarter ending 2015-09-30 was $0.00, a 100.00% decline year-over-year.
- TETRAPHASE PHARMACEUTICALS INC accretion expense for the quarter ending 2015-06-30 was $0.00, a 100.00% decline year-over-year.
- TETRAPHASE PHARMACEUTICALS INC accretion expense for the quarter ending 2015-03-31 was $45.00K, a 18.42% increase year-over-year.
- TETRAPHASE PHARMACEUTICALS INC accretion expense for fiscal 2015 was $45.00K, a 60.87% decline from fiscal 2014.
- TETRAPHASE PHARMACEUTICALS INC accretion expense for fiscal 2014 was $115.00K, a 42.21% decline from fiscal 2013.
- TETRAPHASE PHARMACEUTICALS INC accretion expense for fiscal 2013 was $199.00K, a 55.47% increase from fiscal 2012.
- TETRAPHASE PHARMACEUTICALS INC accretion expense for fiscal 2012 was $128.00K.
| Period end | Accretion Expense 3 month | Accretion Expense 6 month | Accretion Expense 9 month | Accretion Expense 12 month | Accretion Expense 81 month | Accretion Expense 84 month | Accretion Expense 87 month | Accretion Expense 90 month | Accretion Expense 93 month |
|---|---|---|---|---|---|---|---|---|---|
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-06 | $0.00 derived: sum of 2 quarters · filed 2018-03-06 | $0.00 derived: sum of 3 quarters · filed 2018-03-06 | $45.00K 10-K · filed 2018-03-06 | |||||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $0.00 derived: sum of 2 quarters · filed 2016-11-03 | $45.00K 10-Q · filed 2016-11-03 | $64.00K derived: sum of 4 quarters · filed 2017-03-13 | |||||
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $45.00K 10-Q · filed 2016-08-04 | $64.00K derived: sum of 3 quarters · filed 2017-03-13 | $90.00K derived: sum of 4 quarters · filed 2017-03-13 | |||||
| 2015-03-31 | $45.00K 10-Q · filed 2016-05-04 | $64.00K derived: sum of 2 quarters · filed 2017-03-13 | $90.00K derived: sum of 3 quarters · filed 2017-03-13 | $122.00K derived: sum of 4 quarters · filed 2017-03-13 | |||||
| 2014-12-31 | $19.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | $45.00K derived: sum of 2 quarters · filed 2017-03-13 | $77.00K derived: sum of 3 quarters · filed 2017-03-13 | $115.00K 10-K · filed 2017-03-13 | |||||
| 2014-09-30 | $26.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | $58.00K derived: sum of 2 quarters · filed 2015-11-02 | $96.00K 10-Q · filed 2015-11-02 | $140.00K derived: sum of 4 quarters · filed 2016-02-25 | |||||
| 2014-06-30 | $32.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $70.00K 10-Q · filed 2015-08-06 | $114.00K derived: sum of 3 quarters · filed 2016-02-25 | $164.00K derived: sum of 4 quarters · filed 2016-02-25 | |||||
| 2014-03-31 | $38.00K 10-Q · filed 2015-05-07 | $82.00K derived: sum of 2 quarters · filed 2016-02-25 | $132.00K derived: sum of 3 quarters · filed 2016-02-25 | $187.00K derived: sum of 4 quarters · filed 2016-02-25 | $364.00K 10-Q · filed 2014-05-12 | ||||
| 2013-12-31 | $44.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $94.00K derived: sum of 2 quarters · filed 2016-02-25 | $149.00K derived: sum of 3 quarters · filed 2016-02-25 | $199.00K 10-K · filed 2016-02-25 | $327.00K 10-K · filed 2014-03-06 | ||||
| 2013-09-30 | $50.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $105.00K derived: sum of 2 quarters · filed 2014-11-10 | $155.00K 10-Q · filed 2014-11-10 | $283.00K 10-Q · filed 2013-11-14 | |||||
| 2013-06-30 | $55.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12 | $105.00K 10-Q · filed 2014-08-12 | $233.00K 10-Q · filed 2013-08-12 | ||||||
| 2013-03-31 | $50.00K 10-Q · filed 2014-05-12 | $178.00K 10-Q · filed 2013-05-13 | |||||||
| 2012-12-31 | $128.00K 10-K · filed 2015-03-06 |